Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-31T09:16:22.427Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of Decolonization to Prevent Staphylococcal Infections in Various Healthcare Settings: Results of an Emerging Infections Network Survey

Published online by Cambridge University Press:  02 January 2015

Sarah Klizas West ,
Melissa S. Plantenga ,
Larry J. Strausbaugh  and
Infectious Diseases Society of America Emerging Infections Network
Sarah Klizas West
Affiliation:
Division of Infectious Diseases, Department of Medicine, Oregon Health and Science University, Portland, Oregon
Melissa S. Plantenga
Affiliation:
Research Service, Veterans Affairs Medical Center, Portland, Oregon
Larry J. Strausbaugh*
Affiliation:
Division of Infectious Diseases, Department of Medicine, Oregon Health and Science University, Portland, Oregon Research Service, Veterans Affairs Medical Center, Portland, Oregon Infectious Diseases Section, Division of Hospitaland Specialty Medicine, Veterans Affairs Medical Center, Portland, Oregon
*
Division of Infectious Diseases (L-457), Oregon Health andScience University, 3181 SW Sam Jackson Park Road NRC3, Portland, OR 97239-3098 (strausba@ohsu.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Less than 20% of infectious diseases consultants work in hospitals that routinely employ decolonization therapy for individuals with staphylococcal carriage undergoing elective surgical procedures or for infection control efforts to limit nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA). However, infectious diseases consultants frequently encounter patients with recurrent MRSA furunculosis and attempt to decolonize them.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 9 , September 2007 , pp. 1111 - 1113
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Boyce, JM. MRSA patients: Proven methods to treat colonization and infection. J Hosp Infect 2001;48(suppl):S9–S14.Google Scholar
2. Kallen, AJ, Wilson, CT, Larson, RJ. Perioperative intranasal mupirocin for the prevention of surgical site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005;26:916–922.Google Scholar
3. Arnold, MS, Dempsey, JM, Fishman, M, et al. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 2002;23:69–76.CrossRefGoogle ScholarPubMed
4. Muto, CA, Jernigan, JA, Ostrowsky, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus . Infect Control Hosp Epidemiol 2003;24:362–386.Google Scholar
5. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network. The Emerging Infections Network: a new venture for the Infectious Diseases Society of America. Clin Infect Dis 1997;25:34–36.Google Scholar
6. Perl, TM, Cullen, JJ, Wenzel, RP, et al. Intranasal mupirocin to prevent post-operative Staphylococcus aureus infection. N Engl J Med 2002;346:1871–1877.Google Scholar
7. Bradley, SF, Ramsey, MA, Morton, TM, Kauffman, CA. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 1995;16:354–358.Google Scholar
8. Harbarth, S, Dharan, S, Liassine, N, et al. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of mefhicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 1999;43:1412–1416.Google Scholar
9. Embil, JM, Oliver, ZJ, Mulvey, MR, Trepman, E. A man with recurrent furunculosis. CMAJ 2006;175:143–144.CrossRefGoogle Scholar